Cryoport Inc
NASDAQ:CYRX

Watchlist Manager
Cryoport Inc Logo
Cryoport Inc
NASDAQ:CYRX
Watchlist
Price: 10.56 USD 0.57%
Market Cap: 528.7m USD
Section:
 

Relative Value

The Relative Value of one CYRX stock under the Base Case scenario is hidden USD. Compared to the current market price of 10.56 USD, Cryoport Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CYRX Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

2.8
P/S
P/S
Price to Sales
2.8
vs History
65
vs Industry
56
Median 3Y
2.5
Median 5Y
3.7
Industry
2.4
Forward
3
More Details
8.9
P/E
P/E
Price to Earnings
8.9
vs History
0
vs Industry
Median 3Y
-3.2
Median 5Y
-6.9
Industry
22.9
Forward
7.6
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
0
Median 3Y
-30.8
Median 5Y
-32.1
Industry
14.7
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-8.9
Median 5Y
-3.8
Industry
21.4
More Details
1
P/B
P/B
Price to Book Value
1
vs History
69
vs Industry
69
Median 3Y
1.1
Median 5Y
1.7
Industry
2.3
More Details
1.5
EV/S
EV/S
Enterprise Value to Sales
1.5
vs History
71
vs Industry
61
Median 3Y
1.6
Median 5Y
3.4
Industry
2.6
Forward
1.7
More Details
3.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.3
vs History
73
vs Industry
60
Median 3Y
3.8
Median 5Y
8.1
Industry
5.3
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-12.6
Median 5Y
-8.8
Industry
12.3
Forward
-70.1
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-6.1
Median 5Y
-6.9
Industry
17.2
Forward
-7.2
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
0
Median 3Y
-16.4
Median 5Y
-19.5
Industry
15
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-8.8
Median 5Y
-23.4
Industry
19
More Details
0.9
EV/IC
EV/IC
Enterprise Value to IC
0.9
vs History
69
vs Industry
74
Median 3Y
0.9
Median 5Y
1.6
Industry
1.9
More Details

Multiples Across Competitors

CYRX Competitors Multiples
Cryoport Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Cryoport Inc
NASDAQ:CYRX
528.7m USD 2.8 8.9 -25.7 -7.2
US
Abbott Laboratories
NYSE:ABT
219B USD 5 15.7 20 27.8
US
Intuitive Surgical Inc
NASDAQ:ISRG
210.2B USD 21.9 76.5 58.7 71.6
US
Boston Scientific Corp
NYSE:BSX
144.7B USD 7.5 51.9 30.3 41.2
US
Stryker Corp
NYSE:SYK
140.5B USD 5.8 47.7 23.2 28.2
IE
Medtronic PLC
NYSE:MDT
125B USD 3.6 26.2 14.8 21.4
DE
Siemens Healthineers AG
XETRA:SHL
52.2B EUR 2.2 24.4 13.7 19.3
US
Becton Dickinson and Co
NYSE:BDX
57.9B USD 2.6 34.5 12.7 21.6
US
IDEXX Laboratories Inc
NASDAQ:IDXX
57.1B USD 13.7 55.5 39.9 44.2
US
Edwards Lifesciences Corp
NYSE:EW
49.4B USD 8.4 36.1 25.8 28.3
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
39.8B USD 2 17.9 13.3 16.1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Cryoport Inc
NASDAQ:CYRX
Average EV/EBITDA: 25.2
Negative Multiple: -25.7 		N/A N/A
US
Abbott Laboratories
NYSE:ABT
20
12%
1.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
58.7
26%
2.3
US
Boston Scientific Corp
NYSE:BSX
30.3
22%
1.4
US
Stryker Corp
NYSE:SYK
23.2
13%
1.8
IE
Medtronic PLC
NYSE:MDT
14.8
8%
1.8
DE
Siemens Healthineers AG
XETRA:SHL
13.7
11%
1.2
US
Becton Dickinson and Co
NYSE:BDX
12.7
9%
1.4
US
IDEXX Laboratories Inc
NASDAQ:IDXX
39.9
14%
2.8
US
Edwards Lifesciences Corp
NYSE:EW
25.8
13%
2
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
13.3
10%
1.3

See Also

Summary
CYRX intrinsic value, competitors valuation, and company profile.
DCF Valuation
CYRX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CYRX stock valuation using valuation multiples.
Wall Street Estimates
CYRX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CYRX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 309,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.